Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs-a multicenter, double-blind, parallel-group trial
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-10-01
著者
-
MIYASAKA Nobuyuki
Tokyo Medical and Dental University
-
YAMAMOTO Kazuhiko
The University of Tokyo
-
KAWAI Shinichi
Toho University Omori Medical Center
-
TAKEUCHI Tsutomu
Saitama Medical Center/School
-
Takeuchi Tsutomu
Keio Univ. School Of Medicine Tokyo Jpn
-
TANAKA Yoshiya
University of Occupational and Environmental Health
-
Kawai Shinichi
Division Of Rheumatology Department Of Internal Medicine (omori) School Of Medicine Faculty Of Medicine
-
YAMAMOTO Kazuhiko
Tokyo University
関連論文
- A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs
- Systemic lupus erythematosus complicated by recurrent pneumothorax : Case report and literature review
- Elevated Serum Levels of Resistin, Leptin, and Adiponectin are Associated with C-reactive Protein and also Other Clinical Conditions in Rheumatoid Arthritis
- Clinical and Radiological Features of Acute-Onset Diffuse Interstitial Lung Diseases in Patients with Rheumatoid Arthritis Receiving Treatment with Biological Agents: Importance of Pneumocystis Pneumonia in Japan Revealed by a Multicenter Study
- Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
- Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI) : significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition
- Pharmacokinetic study and Fcγ receptor gene analysis in two patients with rheumatoid arthritis controlled by low-dose infliximab
- -149-EXPRESSION OF INTERLEUKIN 1 IN DCM HEARTS : Cardiomyopathy : FREE COMMUNICATIONS(I) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
- A case of systemic sclerosis complicated by idiopathic portal hypertension : case report and literature review
- Effects of Aphidicolin on Entamoeba histolytica Growth and DNA Synthesis
- Inhibition of Encystation of Entamoeba invadens by Aphidicolin
- Comparison of DNA polymerase between Entamoeba histolytica and E. dispar
- Efficacy and safety of tacrolimus for lupus nephritis : a placebo-controlled double-blind multicenter study
- Safety of long-term tacrolimus therapy for rheumatoid arthritis : an open-label, uncontrolled study in non-elderly patients
- Asymptomatic cyst passers of Entamoeba histolytica but not Entamoeba dispar in institutions for the mentally retarded in Japan
- Induction of permeability changes and death of vertebrate cells is modulated by the virulence of Entamoeba spp. isolates
- The application of the atomic force microscope to studies of medically important protozoan parasites
- Tacrolimus therapy for systemic lupus erythematosus without renal involvement : a preliminary retrospective study
- Pro-apoptotic effect of nonsteroidal anti-inflammatory drugs on synovial fibroblasts
- Recent Advances in Nonsteroidal Anti-Inflammatory Drugs
- Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiograp
- Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
- Identification of an avirulent Entamoeba histolytica strain with unique tRNA-linked short tandem repeat markers
- Serum adipokine profiles in Kawasaki disease
- Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs-a multicenter, double-blind, parallel-group trial
- A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis
- Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients : postmarketing surveillance report of the first 3,000 patients
- Assessing the Cardiovascular Risk Between Celecoxib and Nonselective Nonsteroidal Antiinflammatory Drugs in Patients With Rheumatoid Arthritis and Osteoarthritis:– A 3-Year Nationwide Comparative Observational Study in Japan (ACCEPT) –
- A Feasibility Study Assessing Tolerability of Daily versus Twice Weekly Trimethoprim-Sulfamethoxazole Regimen for Prophylaxis against Pneumocystis Pneumonia in Patients with Systemic Autoimmune Diseases on Glucocorticoid Therapy
- Resistin is associated with the inflammation process in patients with systemic autoimmune diseases undergoing glucocorticoid therapy : comparison with leptin and adiponectin